Erectile and endothelial dysfunction in type II diabetes: A possible link

Diabetologia

Volumn 44, Issue 9, 2001, Pages 1155-1160

  De Angelis, L ^a   Marfella, M A ^a   Siniscalchi, M ^a   Marino, L ^a   Nappo, F ^a   Giugliano, F ^a   De Lucia, D ^a   Giugliano, D ^a  

^a NONE   (Italy)

Author keywords

Adhesion molecules; Coagulation; Endothelial functions; Erectile dysfunction; Fibrinolysis; L arginine test; Peripheral neuropathy; Thrombomodulin

Indexed keywords

CELL ADHESION MOLECULE; HEMOGLOBIN A1C; THROMBIN; THROMBOMODULIN;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCORING SYSTEM; VASCULAR ENDOTHELIUM;

ARGININE; BLOOD COAGULATION; BLOOD PRESSURE; CELL ADHESION MOLECULES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMPOTENCE; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION; THROMBOMODULIN;

EID: 0034840292     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100616     Document Type: Article

References (40)

1. Impotence and its medical and psychosocial correlates: Results of the Massachussets male aging study
2. New insights into erectile dysfunction: A practical approach
3. Sexual dysfunction in diabetic men
4. The prevalence of diabetic impotence
5. Diabetes and vascular impotence: Does insulin dependence increase the severity?
6. Impotence
7. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle
8. Nitric oxide release accounts for the biological activity of the endothelium-derived relaxing factor
9. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
10. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
11. Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?
12. Impotence
13. The International Index of Erectile Function (IIEF)
14. L-arginine for testing endothelium-dependent vascular functions in humans
15. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects
16. Quantitative sensory assessment
17. The squatting test. A useful tool to assess both parasympathetic and sympathetic involvement of the cardiovascular autonomic neuropathy in diabetes
18. Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM
19. Impotence in diabetes: The neurologic factor
20. Consensus document - Glycemic control and cardiovascular diseases in type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin
21. Erectile dysfunction in diabetic subjects in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile
22. Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici
23. Thrombomodulin and coronary heart disease
24. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes
25. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) study: A case-control study
26. Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
27. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy
28. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine
29. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients
30. Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia
31. Oxidative stress and diabetic vascular complications
32. Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin
33. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS
34. Vascular thrombosis in type II diabetes mellitus
35. Assessment of hypercoagulable states by measurement of activation fragments and peptides
36. Coagulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects
37. Physiology of penile erection
38. The value of testing for unmyelinated fibre, sensory neuropathy in diabetic impotence
39. Polyneuropathy in impotence
40. Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction